Background: The labile state of short-term memory has been known for more than a century. It has been frequently reported that immediate postlearning intervention can readily disrupt newly formed memories. However, the molecular and cellular mechanisms underlying the labile state of new memory are not understood. Results: Using a bump-and-hole-based chemical-genetic method, we have rapidly and selectively manipulated aCaMKII activity levels in the mouse forebrain during various stages of the short-term memory processes. We find that a rapid shift in the aCaMKII activation status within the immediate 10 min after learning severely disrupts short-term memory formation. The same manipulation beyond the 15 min after learning has no effect, suggesting a critical time window for CaMKII action. We further show that during this same 10 min time window only, shifting in CaMKII activation state is capable of altering newly established synaptic weights and/or patterns. Conclusion: The initial 10 min of memory formation and longterm potentiation are sensitive to inducible genetic upregulation of aCaMKII activity. Our results suggest that molecular dynamics of CaMKII play an important role in underlying synaptic labile state and representation of short-term memory during this critical time window.
Introduction
Short-term memory is known to be in a highly labile state before it is transformed into a longer-lasting, more stable form [1, 2] . Over the past several decades, many experiments have shown that immediate postlearning electroconvulsive shock (ECS) can induce retrograde amnesia, indicating the existence of a time window during which newly formed memory is in a highly labile state [3] . This labile phase of short-term memory is thought to be mechanistically distinct from the protein-synthesis-dependent consolidation phase of long-term memory [4, 5] . Currently, little is known regarding the temporal dynamics and molecular basis underlying the labile state of short-term memory.
CaMKII is a molecule that plays a major role in mediating the NMDA-receptor signaling involved in synaptic plasticity and formation of associative memories in the brain [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . It is believed that Ca 2+ activates CaMKII through the NMDA receptor; CaMKII in turn causes the translocation of the holoenzyme to postsynaptic density (PSD) and the subsequent retention via physical binding to the NR2B subunit of the NMDA receptor at the synapses [16] [17] [18] [19] [20] . Autophosphorylation at the Thr286 site of aCaMKII further enhances its binding affinity to Ca 2+ /CaM and prolongs the association of CaMKII at PSD [16, [21] [22] [23] . It has been suggested that the activated CaMKII at the PSD zone is responsible for potentiating synapses, probably via synaptic insertion or increasing channel conductance of the AMPA receptor [24, 25] . Thus, the CaMKII's persistent ''on'' state induced by long-term potentiation (LTP) stimulation may allow the CaMKII to serve as a memory device for information storage [26] . Consistent with this general idea, several genetically modified mice carrying null mutations or point mutations in aCaMKII have exhibited deficits in memory tests [27, 28] .
Inducible and region-specific gene knockout (third-generation gene knockout) techniques are valuable for molecular and temporal analysis of biological processes [29, 30] . However, because the inactivation event occurs at the DNA level, manifestation of any phenotype depends on the turnover rate of the existing protein, which may require days or even weeks. This inherently slow process has excluded precise investigation of many in vivo biological processes that occur within minutes and hours, such as short-term memory.
Recently, we have developed an inducible-protein-knockout technology by integrating convergent protein engineering and rational inhibitor design [31, 32] . This method is based on the bump-and-hole approach that creates a specific interaction interface between a modified protein domain and sensitized inhibitors. By introducing this system into genetically modified mice, we can readily and specifically manipulate the activity of a targeted protein, such as CAMKII, in the subregion(s) of the brain in freely behaving mice on the time scale of a few minutes [31, 33] . Here, our combined electrophysiological and behavioral analyses suggest that the molecular dynamics of aCaMKII underlie the labile state of short-term memory.
Results

Rapid Manipulation of aCaMKII Activity in the Transgenic Mouse Forebrain
To investigate the role of CaMKII in regulating the temporal labile stage of short-term memory during its initial formation, we used inducible, reversible, and forebrain-specific CaMKII transgenic mice generated by a bump-and-hole-based chemical-genetic method [31] . Our overall strategy involved transgenic overexpression of aCaMKII-F89G transgene, which encodes aCaMKII with wild-type-like catalytic activity but carries an extra hidden cavity inside of its ATP-binding pocket ( Figure 1A ). This ''enlarged'' mutant aCaMKII can be selectively inhibited by a rationally designed, genetically sensitized small-molecule inhibitor, NM-PP1 [31, 33] . We confirmed the forebrain specificity of the transgene expression in the offspring of our transgenic mice ( Figure 1B ).
In these transgenic mice, a single intraperitoneal (i.p.) injection of NM-PP1 (5 mM) is shown to be capable of suppressing CaMKII-F89G activity in the forebrain regions within 8 min, consequently bringing the total amount of CaMKII activity in the transgenic forebrain back to the normal wild-type levels ( Figure 1C ). This inhibition is readily reversible in approximately 40 min, as demonstrated both by pharmacokinetics and enzyme-activity assay in Tg-F89G mice. This time course fits well with the measured pharmacokinetics of 3 H-labeled NM-PP1 ( Figure 1C ). Thus, a single i.p. injection of NM-PP1 into freely behaving transgenic mice can completely suppress aCaMKII-F89G activity and consistently maintain total CaMKII activity at the wild-type level between 10 and 40 min after injection. We used these pharmacokinetics as a guide for manipulating CaMKII activity in transgenic mice during our behavioral experiments. Our previous study shows that NM-PP1 has no effect on wild-type mice [31] .
Acquisition of Short-Term Memory with Normal or Elevated CaMKII Activity
To determine whether the activation state of CaMKII plays a role in the representation of short-term memory in the brain, we examined individual temporal stages of 1 hr short-term memory processes. We have chosen three different behavioral paradigms, namely novel-object-recognition memory, contextual-fear memory, and cued-fear memory. All behavioral experiments were performed on the littermate wild-type and transgenic mice and conducted by the two and/or three experimenters blind to the genotype of each mouse.
We first conducted the novel-object-recognition short-term memory tests (with 1 hr retention) in transgenic aCaMKII-F89G mice and their littermate controls. Animals were allowed to explore two objects in an open field for 15 min. One of the two objects was replaced with a novel one 60 min later, and the mice were allowed to explore them for 5 min. The memory performance was evaluated by the time spent on the novel objects.
We allowed learning to occur in the temporally restricted presence of elevated CaMKII (no NM-PP1 inhibition), which is known to change plasticity-frequency responses in the transgenic brain [31] . A single i.p. injection can provide consistent and complete in vivo inhibition of aCaMKII-F89G activity in the transgenic mice between 8 and 35 min after injection and partial inhibition during the initial 3-8 min as well as during the last 35-40 min after injection [31] . Therefore, we designed a two-injection protocol so that we could suppress aCaMKII-F89G activity for more than 60 min. Immediately after the training session was completed (within 10-30 s), we administered the first i.p. injection of NM-PP1; we administered the second injection 30 min after the first injection so that we could suppress aCaMKII-F89G in transgenic mice throughout the rest of the experiments (including at the time of recall, conducted at the end of 1 hour retention). The temporally restricted presence of overexpressed CaMKII-F89G kinase activity in the transgenic mice during the learning stage (without NM-PP1 inhibition) is indicated by a black bar above the timeline at the top of Figure 2 . Under this ''learning-with-elevated-CaMKII'' paradigm, we found that transgenic mice showed normal acquisition and retention of the memory in comparison to that of wild-type littermate mice (Figure 2A ). This suggests that the elevation of forebrain CaMKII activity during learning does not impair the acquisition of short-term recognition memory.
We then conducted the learning-with-elevated-CaMKII experiments with fear conditioning tasks. Mice were given a pairing of a tone with a mild foot shock, and memory performance was evaluated as the percentage of time spent on freezing in response to the same training chamber (contextual freezing) or to the same tone with a different testing chamber (cued freezing) 60 min after training. Again, we found that transgenic mice with the transient CaMKII-F89G expression during learning exhibited normal performance in comparison to their wild-type littermates in either the 1 hr short-term contextual memory test ( Figure 2B ) or cued memory test ( Figure 2C) . Thus, the transgenic mice can learn normally regardless whether they have the normal (with NM-PP1 treatment) or higher amount (without NM-PP1 treatment) of CaMKII activity during the acquisition phase.
Next, we asked whether the transgenic mice can acquire and retain short-term memory when CaMKII-F89G is present not only during learning, but also during the following 55 min until memory is recalled. This ''learning/retention-with-elevated-CaMKII'' paradigm would allow us to further determine whether the continuous presence of CaMKII-F89G kinase activity during this period alters short-term memories. Similar to their performance in the learning-with-elevated-CaMKII paradigm, transgenic mice showed normal acquisition and retention of the visual memory in comparison to that of wild-type littermate mice in the novel-object-recognition test ( Figure 2D ). Moreover, behavioral performances of transgenic mice in the 1 hr contextual ( Figure 2E ) and cued retention tests ( Figure 2F ) were also indistinguishable from those of their wild-type littermates. Therefore, the persistent presence of CaMKII-F89G in the forebrain during learning and postlearning retention periods did not affect memory formation.
Disruption of Short-Term Memory by Shifting Learned Synaptic States
To investigate whether a postlearning shift in CaMKII activity disrupts neural representation of short-term memory, we trained a group of transgenic mice under conditions in which aCaMKII-F89G activity was unmasked immediately after memory acquisition (<5 min), and we allowed aCaMKII-F89G enzymatic activity to be expressed between the initial 5 and 35 min (see the black bar on top of Figures 3A-3C , which indicates the duration of the availability of aCaMKII-F89G).
We first conducted this ''unmasking-CaMKIIF89G-immediately-after-learning'' protocol with the novel-object-recognition test. We observed that such an upward shift severely disrupted 1 hr retention of recognition memory ( Figure 3A ; ANOVA F (1,9) = 38, p < 0.001). Similarly, we found the profound retention deficits in the short-term contextual-fear memory test ( Figure 3B ; ANOVA F (1,11) = 12.29, p < 0.01) as well as the short-term cued-fear memory test ( Figure 3C ; ANOVA F (1,11) = 13.95, p < 0.01). The data suggest that short-term memory seems to be maintained in a synaptically labile state that is highly sensitive to postlearning numerical increase in CaMKII activity.
To further determine the duration of this CaMKII-mediated labile period of short-term memory, we designed the experiments in which aCaMKII-F89G activity was permitted to be active only between 10 and 40 min after training (see the black bar on top of Figures 3D-3F ) so that a normal amount of CaMKII activity was present in the transgenic mice during memory acquisition, the initial 10 min after training, 40-60 min after training, and recall. Again, we found that such an ''unmasking-CaMKIIF89G-within-10-minutes-after-learning'' protocol also caused profound deficits in the retentions of the Next, we carried out additional temporal analysis and designed the ''unmasking-CaMKIIF89G-within-15-minutesafter-learning'' protocol in which aCaMKII-F89G activity would be unmasked only between 15 and 45 min after training (see the black bar on top of Figures 4A-4C ). Under this protocol, we observed that the transgenic mice showed normal retentions in the novel-object-recognition ( Figure 4A ), contextualfear ( Figure 4B ), and cued-fear memory tests ( Figure 4C ). These experiments suggest that there is a critical time window (<15 min) during which short-term memories are sensitive to disruption by upward shift in CaMKII, and they also suggest that removal of NM-PP1 inhibition of aCaMKII-F89G activity beyond this time window can no longer disrupt short-term memories.
Finally, we conducted a set of ''unmasking-CaMKIIF89G-25-minutes-after-learning'' experiments in which aCaMKII-F89G activity was made available selectively between 25 and 55 min after training (see the black bar on top of Figures 4D-4F ). Once again, we found that late-stage removal of aCaM-KII-F89G inhibition did not produce detrimental effects on the retentions in the novel-object-recognition ( Figure 4D ), contextual-fear ( Figure 4E ), and cued-fear memory tests ( Figure 4F ). These results demonstrate that the critical time window of the CaMKII-mediated labile period for three types of shortterm memory is restricted to the initial 10 min after learning.
Temporal Dynamics of CaMKII in Hippocampal Long-Term Potentiation
To determine the effects of molecular dynamics of activated aCaMKII-F89G on synaptic plasticity, we measured LTP in the Schaffer collateral pathway with extracellular field recordings in CA1 regions of hippocampus in both transgenic and control slices. We found that single tetanus (100 Hz, 1 s) evoked larger LTP in transgenic slices in comparison to that in control slices ( Figure 5A, ANOVA F (1,19) = 5.259, p < 0.05). This enhanced LTP can be reduced to the wild-type level by (E) Disruption of contextual-fear memory in transgenic mice by the early-stage unmasking aCaMKII-F89G activity. Although there is no significant difference between two groups in immediate freezing, a significantly lower freezing response during the 1 hr contextual retention test was found in transgenic mice (n = 10) in comparison to that of wild-type mice (n = 10) (F (1,18) = 39.76, p < 0.01). (F) Disruption of cued-fear memory in transgenic mice by the early-stage unmasking aCaMKII-F89G activity. Although there is no significant difference between two groups in pre-tone freezing, a significantly lower freezing response in the 1 hr cued retention test was found in transgenic mice (n = 10) in comparison to that of wild-type mice (n = 10) (F (1,18) = 27.03, p < 0.01). All values are mean 6 SEM. One-way ANOVA-Tukey was used for all the statistical analyses (**p < 0.01).
the application of NM-PP1 (5 mM) in the recording chamber throughout the experiments ( Figure 5B ). Interestingly, posttetanus application of NM-PP1 had no effect on LTP levels in transgenic hippocampal slices ( Figure 5C ; ANOVA F (1,26) = 4.692, p < 0.05), suggesting that once CaMKII is activated by LTP, inhibition of CaMKII activity could not readily reverse the phosphorylation-triggered downstream events [14, 34] .
We then asked whether aCaMKII-F89G remains in a conformationally active state after tetanic stimulation (e.g., binding with Ca 2+ /CaM triggers translocation of the CaMKII to the PSD zone) [16, 22, 23] . We reasoned that if aCaMKII-F89G is locked in an active conformation during this transient period, quick removal of NM-PP1 immediately after tetanus would unmask the ''conformationally activated'' CaMKII-F89G activity and subsequently shift the established population LTP to a higher level. To test this idea, we designed an experimental protocol in which the hippocampal slices were treated with NM-PP1 for a fixed duration, starting 10 min before the tetanus and continuing for an additional 5 min after the tetanus before being washed out. Interestingly, we found that such a manipulation shifted the otherwise normal-level LTP to a higher level in transgenic slices ( Figure 6A ; ANOVA F (1,18) = 6.072, p < 0.05).
To further examine the duration of this critical time window, we conducted another set of the recording experiments with a similar protocol, except the drug was washed out at 10 min after tetanus. Again, we observed the similar effect in shifting LTP to a higher level ( Figure 6B ; ANOVA F (1,17) = 5.166, p < 0.05), although we noticed that the level of shift seemed to be smaller than that of the 5 min washout experiments. Next, we conducted additional sets of recording experiments in which the washout was carried out 15 min after tetanic stimulation. This time, no shift could be produced in the transgenic slices ( Figure 6C ). Furthermore, we observed no effect of unmasking aCaMKII-F89G activity on the established LTP if NM-PP1 was washed out 30 min after tetanus stimulation ( Figure 6D ). Therefore, these results together have demonstrated that the early-stage removal of NM-PP1 within the temporally restricted critical time window (%10 min) after stimulation could readily unmask conformationally activated aCaMKII-F89G activity, leading to upward shifts in the population level or network pattern of synaptic potentiation. This finding suggests that the molecular and temporal dynamics of CaMKII play a crucial role in controlling the early labile phase of synaptic potentiation.
Discussion
A half century ago, Hebb and Gerard proposed a dual-trace theory of memory, suggesting that short-term memory traces are represented in a labile and short-lasting neural state before transforming into long-term memory [1, 2] . Their proposals have led to numerous studies, which show that postlearning administration of electroconvulsive shock, brain impact, traumatic injury, and seizures appear to preferentially disrupt short-term memories, whereas those same types of interventions leave long-term memory largely intact.
We have chosen three different forms of short-term memory tests for the analysis of the molecular and synaptic mechanism underlying the labile period of newly formed memory. All these behavioral tests involve a single training session, and memory acquisitions are dependent on the NMDA receptors [33, [35] [36] [37] [38] . More importantly, the novel-object-recognition memory tends to only last for several days, whereas contextual-and cued-fear memories can last for months and even years, thereby providing an opportunity to compare the initial stages of these memory processes known to have distinct durations. In addition, these three behavioral tests are known to involve different neuronal circuits. Thus, these different behavioral paradigms have allowed us to measure and directly compare whether the initial labile states of those short-term memories share any commonality.
Using these tasks, we systematically switched on and off the transgenically expressed aCaMKII-F89G activity in freely behaving mice and asked how the shift of CaMKII activity alters short-term memory. Our experiments demonstrate that the initial 10 min period represents the critical time window during which both potentiated synapses and short-term memory are in an especially labile state and are sensitive to numerical increases in CaMKII activity.
What temporal dynamics of activated CaMKII might underlie this critical time window? On the basis of the available literature, it seems that dynamics of CaMKII translocation to and disassociation from the PSD could underlie what we observed at the synaptic and behavioral levels ( Figure 6E ). During this PSD-association period, removal of NM-PP1 inhibitor from transgenic CaMKII-F89G ATP-binding pocket can unmask the activated CaMKII-F89G activity, leading to a rapid shift of synaptic weight from the existing state to a new state. Such a switch of synaptic patterns in a given neural network would then disrupt the ongoing memory representation. However, once the CaMKII complex is disassociated from the PSD, unmasking of aCaMKII-F89G activity no longer causes any significant alteration in the patterns of potentiated synapses and neurons, thereby having no disruptive effects on shortterm memory representation. There are at least two factors that may control the dissociation of CaMKII from PSD: (1) secondary phosphorylation on Thr305/306 of CaMKII, which is reported to promote disassociation of the enzyme from PSD [20, 22] , and (2) dephosphorylation at the Thr286 site by phosphatase 1 action because both PP1 inhibitor and T286D mutant delayed the dissociation of CaMKII from PSD [22] , which suggests that the dephosphorylation of the autonomous phosphorylation site T286 is required for dissociation. Consistent with our results, the studies in cultured neurons indicate that the disassociation of CaMKII complex from PSD occurs within minutes [22, 23] .
Although we have demonstrated that numerical increase in activated CaMKII activity can lead to changes in the established LTP level, we currently do not know whether such changes were due to increased single-channel conductance of AMPA receptors at these synapses [24] , increased insertion of AMPA receptors [25, 39] , or activation of other proteins, such as those postulated to be involved in the ''synaptic tagging'' process [40] [41] [42] . If potentiation of individual synapses is an ''all-or-none'' process [43] , the upward shift in population LTP by unmasking aCaMKII-F89G at PSD could be a result of an increase in the total numbers of potentiated synapses (network patterns of activated synapses). On the other hand, if potentiation of individual synapses is a graded process, the upward shift in LTP would come from an increase in the degree of potentiation in the same set of synapses.
It is important to point out that although the measurement of experimental form of synaptic plasticity from the hippocampus of CaMKII-F89G transgenic mice is informative, we do not know whether and how such changes in synaptic plasticity measured in hippocampal slices (e.g., at 28 C) reflect in vivo synaptic changes induced by natural learning (at 37 C). Moreover, it would be useful to further examine the role of endogenous aCaMKII function with a knockin method (such as replacing one or both copies of the aCaMKII gene with aCaMKII-F89G). One traditional approach to the study of endogenous gene function is to perform knockout experiments. However, in the case of CaMKII, once activated, this enzyme quickly phosphorylates its downstream substrates. This means that pharmacological inhibition or genetic knockout at this stage will be too late to reverse its consequences, which can only be reversed by phosphates over time. On the contrary, the further upregulation of CaMKIIF89G activation can still alter the downstream signaling process in a rapid manner, thereby revealing important insights about CaMKII dynamics and function. The fact that both heterozygous and homozygous aCaMKII knockouts, as well as several transgenic overexpressors [15, 27, 28, 44] , all produced some types of memoryimpairment phenotypes further supports the notion that the delicate balance between CaMKII and phosphates is crucial for normal memory function. Our present study provides a novel insight into this previously unrecognized role in maintaining short-term memory process.
It is interesting to mention that learning involved in those three types of behavioral tasks is likely to involve many different brain regions; we have not yet examined directly whether (E) Schematic drawing illustrates the molecular dynamics of CaMII at activated synapses. During the initiation phase, learning triggers the activation of the NMDA receptor, which permits Ca 2+ influx, leading to the binding of Ca 2+ /calmodulin to CaMKII, which initiates the dissociation of CaMKII from F-actin (through bCaMKII-mediated action) and then translocation of the complex to PSD. The aCaMKII-F89G-containing holoenzyme in the transgenic animals is capable of translocating to PSD in the presence of NM-PP1 inhibition because the translocation is an autophosphorylation-independent step. Once translocated to PSD via binding to NR2B C-terminal, the active CaMKII potentiates synapses and activates ''synaptic tags.'' During this PSD-associated phase, changes in CaMKII activity (such as unmasking the activated aCaMKII-F89G activity) will lead to resetting of the patterns of potentiated synapses in the network. The dissociation of CaMKII from PSD would make the synapse less vulnerable to the unmasking effect of aCaMKII-F89G activity. The dissociation may be controlled by the dephosphorylation on T286 by phosphatase 1, secondary phosphorylation at inhibitory phosphorylation sites of aCaMKII, and/or bCaMKII activity. similar changes in the plasticity-frequency responses also occurred in other forebrain regions (such as the amygdala or cortex) of our transgenic mice. Nonetheless, our data consistently suggest that a switch between the normal state and higher state in terms of CaMKII-activity level within a certain time window can severely disrupt memory formation [31, 33] . It is important to point out that our previous study has shown that constitutive presence of aCaMKII-F89G during learning and retention periods has no significant effect on memory performances on transgenic mice [31] . This suggests that as long as consistency in CaMKII activity is maintained, learning and consolidation can still occur normally in the brain, even with elevated CaMKII activity and heightened LTP levels. However, alteration in CaMKII level during the first postlearning week disrupts long-term memory consolidation. Furthermore, our more recent study also shows that bCaMKII is also involved during the memory consolidation [33] . Taken together with our present findings, we conclude that memory process is sensitive to numerical changes in CaMKII activity at multiple time windows. It would be of great interest to examine how the rapid changes in CaMKII activation affect neural-network patterns and dynamics during the encoding of episodic memories [45] [46] [47] , especially given the observation that aCaMKII overexpression at the time of recall can lead to rapid erasure of the memory being retrieved [48] .
In conclusion, using the rapid inducible and reversible chemical-genetic technique, we have shown that the initial 10 min of new-memory formation and LTP are sensitive to manipulation of aCaMKII activation state. We conclude that CaMKII activation state plays an important role in regulating synaptic-potentiation dynamics and short-term memory representation.
Experimental Procedures Production and Biochemical Characterizations of Transgenic Mice
The transgenic mice were produced and maintained on the BCF1 hybrid background [31] . The genotype and the expression pattern of the transgene were determined by in situ hybridization with the same protocol [31] . We determined the NM-PP1 pharmacokinetics by using both a radioactive-tracing method and a kinase-activity assay [31] . The time course of single NM-PP1 inhibition on CaMKII from pharmacokinetic studies served as a guideline for the short-term memory analysis. A single i.p. injection of NM-PP1 seems to provide effective inhibition between 10 and 40 min after injection. To ensure the valid NM-PP1 inhibition in vivo, we also measured the off rate of NM-PP1 that may occur during the brain dissection procedure. By carrying out a serial dilution (1:10, 1:100) to the brain homogenates, we found no significant dilution effect on the binding of NM-PP1 on CaMKII in the above assay condition. In addition, we also performed kinase assay to confirm the effective inhibition of CaMKII-F89G activity by NM-PP1 in the transgenic mice receiving the double injection protocols, which were designed to compensate for the rebound of CaMKII-F89G activity after 40 min of a single injection. The specific suppression of CaMKII-F89G activity in those mice receiving double i.p. NM-PP1 injections was listed in the figure legends of 1 hr short-term memory results.
We also measured NM-PP1 pharmacokinetics synthesizing 3 H-labeled NM-PP1 [31] . The injected solution contains the mixture of cold NM-PP1 and 3 H-NM-PP1 at the ratio of 1:100. 10 ml of the body weight of NM-PP1 mixture was i.p. injected into the mice. At each time point, mice were sacrificed, and their forebrains were quickly dissected and weighted. The forebrain tissues were homogenized in 1 3 ice-cold PBS. 200 ml of the homogenate was put into 4 ml of scintillation solution for measurement of radioactivity. The data presented were the percentage of CPM reading from the total forebrain homogenate compared with that of the total amount of NM-PP1 injected into the body.
Hippocampal-Slice Recording
The recording procedures were the same as previously described [8, 28, 31] . In brief, transverse slices of the hippocampus from transgenic and wild-type littermate mice (3-4 months old) were rapidly prepared and maintained in a submerge chamber at 28 C. 5 mM of NM-PP1 was perfused in the indicated slices. A bipolar tungsten stimulating electrode was placed in the striatum radiatum in the CA1 region, and extracellular field potentials were recorded with a glass microelectrode (3-12 MU filled with ACSF), also in the striatum radiatum. Test responses were elicited at 0.017 Hz. In the experiments involving NM-PP1 treatments, the control slices (from wild-type littermates) received the same drug treatment as the transgenic slices during those LTP measurements.
Behavioral Measurements
Mice were maintained in a temperature-controlled environment on a 12 hr light-dark cycle. Adult male CaMKII F89G transgenic and wild-type littermate mice (2-4 month old) were used throughout all behavioral tests. For NM-PP1 treatment, the dose of 16.57 ng per gram of body weight per mouse was used via i.p. injection (5 mM). NM-PP1 was dissolved in DMSO, with a final concentration of 0.02% of DMSO in the solution. All the control animals (wild-type littermates) received the same drug treatment as the transgenic animals during the behavioral experiments.
Novel-Object-Recognition Task and Fear Conditioning
Those behavioral experimental protocols were the same as described previously [8, 29, 36] . For the novel-object-recognition test, a preference index, a ratio of the time spent exploring any one of the two objects (training session) or the novel one (retention session) over the total time spent exploring both objects, was used to measure recognition memory. For fear conditioning, the freezing responses were recorded in a sampling time of 5 s. Data were calculated as mean 6 SEM. One-way ANOVA-Tukey was used for all the statistical analyses.
